Form D — Optimeos Life Sciences, Inc.
0001819114-26-000001 · filed Jun 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,000,000
- Reported amount sold
- $1,000,000
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Optimeos Life Sciences, Inc.
- CIK
- 1819114
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 174 NASSAU STREET, SUITE 334
PRINCETON, NJ 08542 - Phone
- 609-658-9839
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shahram Hejazi · Executive OfficerPrinceton, NJ Find on LinkedIn ↗
-
Robert K Prud'homme · DirectorPrinceton, NJ Find on LinkedIn ↗
-
Jason Smith · DirectorPrinceton, NJ Find on LinkedIn ↗
-
Benjamin Doranz · DirectorPrinceton, NJ Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗